Clinical Research

Laboratorios Cinfa S.A.

Address
Travesia De Roncesvalles 1, Olloki

Sponsor Overview

assignment
16
sponsored trials
science
2
molecules
location_city
3
research centres
public
2
countries
person_search
7
investigators

Specializations

Bioequivalence and Relative Bioavailability

Laboratorios Cinfa S.A. focuses on bioequivalence and relative bioavailability studies in healthy adult volunteers, comparing test and reference formulations under fed and fasting conditions.

  • Comparative bioavailability assessments
  • Test and reference product equivalence
  • Healthy participant studies

These studies support the clinical evaluation of oral medicines intended for use in routine therapeutic settings.

Oral Solid Dosage Forms

The sponsor’s research includes film-coated tablets, modified-release tablets, prolonged-release tablets, and soft capsules, with attention to formulations designed for systemic delivery.

  • Tablet and capsule formulations
  • Modified-release and prolonged-release products
  • Comparative formulation performance

Its portfolio reflects interest in dosage forms used across chronic and acute treatment areas.

Cardiometabolic and Metabolic Disorders

Clinical activity extends to medicines associated with type 2 diabetes, cardiometabolic disease, and related metabolic management, including combinations used to improve glycaemic control.

  • Dapagliflozin
  • Metformin hydrochloride
  • Calcifediol

This area also includes therapies relevant to broader metabolic and endocrine care.

Neurology and Central Nervous System Therapies

The sponsor funds studies of medicines used in neurology and central nervous system care, with interest in agents for seizure control and mood-related disorders.

  • Perampanel
  • Vortioxetine
  • Neurological and psychiatric treatment options

These trials reflect work across both neurological and neuropsychiatric therapeutic domains.

Urology and Anticoagulation

Research also covers therapies used in overactive bladder and thromboembolic risk reduction, including products with established roles in urology and anticoagulation.

  • Mirabegron
  • Apixaban
  • Urological and cardiovascular medicine

These areas broaden the sponsor’s clinical interest across both chronic symptom management and vascular medicine.

Sponsored Trials

Trial Name Country Status
A Bioequivalence Study of Mirabegron 50 mg Prolonged-Release Tablets in Healthy Participants Under Fasting ConditionsPortugal PortugalNot Recruiting
A Bioequivalence Study of Mirabegron 50 mg Prolonged-Release Tablets in Healthy Participants Under Fed ConditionsPortugal PortugalNot Recruiting
A Randomized, Open-Label, Crossover Study to Assess the Relative Bioavailability of Naproxen Sodium 660 mg Modified-Release Tablets in Healthy Adult Subjects Under Fed ConditionsCzechia CzechiaNot Recruiting
A Randomized, Open-Label, Two-Period Crossover Bioequivalence Study Comparing Naproxen Sodium 660 mg Modified-Release Tablets to a Reference Modified-Release Product in Healthy Adults Under Fed ConditionsCzechia CzechiaNot Recruiting
A Randomized, Open-label, Two-period, Crossover Study to Compare the Relative Bioavailability of Naproxen Sodium 660 mg Modified-Release Tablets to a Reference Product in Healthy Volunteers under Fasting ConditionsCzechia CzechiaNot Recruiting
Bioavailability Assessment of Dapagliflozin in a Bioequivalence StudyCzechia CzechiaNot Recruiting
Bioequivalence of Tramadol 200 mg Prolonged‑Release Tablets Under Fed Conditions in Healthy VolunteersCzechia CzechiaNot Recruiting
Bioequivalence Study of Apixaban 5 mg Film-Coated Tablets in Healthy Subjects Under Fasting ConditionsPortugal PortugalNot Recruiting
Bioequivalence Study of Calcifediol Monohydrate 0.266 mg Soft Capsules in Healthy Subjects Under Fasting ConditionsPortugal PortugalNot Recruiting
Bioequivalence Study of Mirabegron 50 mg Prolonged-Release Tablets in Healthy Subjects Under Fasting ConditionsPortugal PortugalNot Recruiting
1–10 of 16
1 / 2

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 2 total (0% not shared with other sponsors)

This sponsor works with 2 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
67%
Return partnership rate
2 of 3 sites collaborated multiple times

This sponsor has worked with 3 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Not possible to specify11 trials
    220 other sponsors
  • 2.
    Nervous System Diseases4 trials
    449 other sponsors
  • 3.
    Cardiovascular Diseases1 trial
    359 other sponsors
  • 4.
    Nutritional and Metabolic Diseases1 trial
    211 other sponsors

Partnered Research Centres

3 centres
location_city
assignment87
Blueclinical Investigacao E Desenvolvimento Em Saude Lda.
Address
Hospital Da Prelada 0 Floor And 3 rd Floor, Rua Sarmento De Beires 153, 4250-449 Porto
Learn morearrow_forward
location_city
assignment42
Quinta-Analytica s.r.o.
Address
Prazska 1486/18c, Hostivar, 102 00 Prague
Learn morearrow_forward
location_city
assignment7
Quinta-Analytica s.r.o.
Address
Umelecka 305/1, Moravska Ostrava, 702 00 Moravska Ostrava A Privoz
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Laboratorios Cinfa S.A..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.